ADMA
ADMA BIOLOGICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$9.11
+1.79%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- $0.19
- Revenue estimate
- $138.1M
Latest reported
- Last report date
- Aug 5, 2026
- EPS actual
- $0.16
- EPS estimate
- $0.16
- Revenue actual
- $124.4M
- Revenue estimate
- $125.3M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- +0.9%
- Revenue beats (12Q)
- 8
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 5, 2026 | $0.16 | $0.16 | Miss -2.02% | $124.4M |
| May 6, 2026 | $0.19 | $0.19 | Miss -1.71% | $114.5M |
| Nov 5, 2025 | $0.16 | $0.16 | In line | $134.2M |
| Aug 6, 2025 | $0.14 | $0.15 | Beat 7.14% | $122.0M |
| Mar 3, 2025 | $0.15 | $0.14 | Miss -6.67% | $117.5M |
| Nov 7, 2024 | $0.13 | $0.15 | Beat 15.38% | $119.8M |
| Aug 8, 2024 | $0.08 | $0.13 | Beat 62.50% | $107.2M |
| May 9, 2024 | $0.06 | $0.08 | Beat 33.33% | $81.9M |
| Feb 28, 2024 | -$0.01 | $0.04 | Beat 420.00% | $73.9M |
| Mar 23, 2023 | -$0.07 | -$0.06 | Beat 14.29% | $50.0M |
| Nov 9, 2022 | -$0.08 | -$0.08 | In line | $41.1M |
| Aug 10, 2022 | -$0.09 | -$0.07 | Beat 22.22% | $33.9M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026